What are C-II drugs characterized by?

C-II drugs, or Schedule II controlled substances, are characterized by accepted medical use and a high potential for severe dependence. This classification reflects the balance between their therapeutic value and the risk of abuse and addiction. Medications in this category can have legitimate medical applications, such as pain management or treatment of certain health conditions, but they also carry a significant risk of leading to psychological or physical dependence when misused.

The definition of C-II substances indicates that although they are recognized for their medical benefits, the potential for abuse is notably higher than that of other controlled substances, classified as Schedule III or lower. This specific distinction is critical in understanding the regulatory environment surrounding these drugs, which includes stringent prescribing and dispensing requirements to minimize their misuse.

In contrast, drugs that are categorized with a low potential for abuse, no accepted medical use, or a potential for abuse less than C-III do not apply to C-II substances. Each of these categories has its own specific regulations and implications in clinical practice and law.